Restricted cash:

At December 31, 2013, restricted cash included $1,000 (2012 - $nil) relating to amounts held in escrow in a non-interest bearing account in connection with the acquisition of Correvio (note 4). This amount will be released from escrow upon the Company’s payment of all amounts owing under the deferred consideration liability plus all applicable accrued interest.

The Company also held restricted cash relating to deposits which are pledged as collateral for bank guarantees for sales contracts with various hospitals and health authorities and for value-added tax liabilities of $1,158 (2012 - $nil) and $165 (2012 -$nil), respectively. Average interest rates on these deposits range from nil to 0.01% (2012- nil).